Atrys Health

Atrys Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Atrys Health (ATRY.MC) as of Oct 8, 2026 is 14.03 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 31.92 % — a change of -56.03% (lower).

FCF Conversion

14.03 %

YoY

-56.03%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Atrys Health is 2025 14.03 % . FCF Conversion Rate (FCF/EBITDA) of Atrys Health was 2024 31.92 % . It decreases by -56.03% lower compared to the previous year.

The Atrys Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-26,708.07 EUR
Jan 1, 2019
3,548.81 EUR
Jan 1, 2020
120.51 EUR
Jan 1, 2021
16.70 EUR
Jan 1, 2022
132.18 EUR
Jan 1, 2023
16.10 EUR
Jan 1, 2024
31.92 EUR
Jan 1, 2025
14.03 EUR
The Atrys Health FCF Conversion history
YEARFCF ConversionYoY
14.03 %-56.03%
31.92 %+98.26%
16.10 %-87.82%
132.18 %+691.66%
16.70 %-86.15%
120.51 %-96.60%
3,548.81 %-113.29%
-26,708.07 %-8,089.75%
334.28 %-108.86%
-3,773.91 %+2,211.20%
-163.29 %—
Access this data via the Eulerpool API
Get Free API Key

Atrys Health Stock analysis

What does Atrys Health do? Atrys Health SA is a leading provider of medical services, founded in 2007 in Madrid, Spain, as a spin-off company of the Clinica Universidad de Navarra. The company's goal is to connect the limitless world of science and technology with the human component of healthcare. The business model of Atrys Health specializes in the development of products, services, and solutions in the field of medical imaging and cancer treatment. The company offers innovative technologies and medical services to help diagnose and treat patients better. Atrys Health consists of different business divisions focusing on the needs of clinical practice, research and development, and biotechnological production. The company aims to improve the efficiency and effectiveness of diagnosis, imaging, and treatment technologies to maximize results. The divisions of Atrys Health focus on various aspects of healthcare, including telemedicine, radiology, and proton therapy. Telemedicine provides a platform for remote treatments and medical consultation, improving access to specialists and enabling fast and effective diagnosis and treatment. The radiology division operates diagnostic centers specializing in medical imaging, equipped with the latest imaging technologies. The proton therapy division operates a proton therapy center in Madrid, offering advanced cancer treatment. Atrys Health offers a range of products tailored to the needs of clinical practice, research and development, and biotechnological production. Their key products include Atrilab, a leading platform for precision oncology diagnostics, Auriculum, a technology for precise radiation in cancer treatments, and Vida Oncology, a software solution for cancer treatment management. In conclusion, Atrys Health is a key player in medical imaging and cancer treatment, improving healthcare globally with advanced technologies and services. With their vision of combining innovative technologies with the human component of healthcare, Atrys Health will continue to lead in the healthcare industry. Atrys Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Atrys Health stock

FCF Conversion Rate (FCF/EBITDA) of Atrys Health is 14.03 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Atrys Health changed from 31.92 % to 14.03 %, representing a -56.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Atrys Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Atrys Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Atrys Health

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Atrys Health